NCT00004229View on ClinicalTrials.gov

Endostatin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

October 31, 2002

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL

recombinant human endostatin

Trial Locations (1)

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH